Crown Laboratories, Inc., a privately held player in the skincare industry, agreed on Monday to acquire Revance Therapeutics, Inc. (NASDAQ:RVNC). Under the terms of the agreement, Crown will commence ...
This Acne Awareness Month, SkinPen and PanOxyl are joining forces for a new campaign spotlighting a holistic approach to acne care. Together, the brands are showcasing how consumers can address both ...
(RTTNews) - Revance Therapeutics, Inc. (RVNC) disclosed on Monday that it has entered into a merger agreement with Crown Laboratories, Inc., which plans to purchase all outstanding shares of Revance's ...
Revance Announces Publication of SAKURA 1 and SAKURA 2 Results in Plastic and Reconstructive Surgery
- Results show DaxibotulinumtoxinA for Injection (DAXI) can reduce frown lines for 24 weeks (approximately 6 months) or more - This manuscript presents the findings from SAKURA 1 and 2 side-by-side, ...
With a new cosmetic dermal filler that works twice as long as AbbVie’s Botox, Nashville, Tennessee, company Revance thought it could capture what it termed the “prestige market.” That, of course, came ...
NASHVILLE, Tenn., March 25, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics, regenerative and consumer skincare company, will showcase the latest innovations and new indications across ...
Milestone underscores rapid growth of microneedling and strong demand for SkinPen NASHVILLE, Tenn., March 31, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics and skincare company, ...
Shares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify, a facial injection drug that Revance hopes will challenge Botox’s ...
Revance Therapeutics (RVNC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stacy Ku from TD Cowen maintained a Buy rating on the stock and has ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that ...
The MarketWatch News Department was not involved in the creation of this content. NASHVILLE, Tenn., March 25, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics, regenerative and consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results